TAM Receptor
TAM Receptor(TAM受体)
TAM receptors (Tyro3, Axl, and Mer) belong to a family of receptor tyrosine kinases that have important effects on hemostasis and inflammation. TAM receptors affect cell proliferation, survival, adhesion, and migration. TAM receptors can be activated by the vitamin K-dependent proteins Gas6 and protein S. Protein S is more commonly known as an important cofactor for protein C as well as a direct inhibitor of multiple coagulation factors.
The TAM receptors-Tyro3, Axl, and Mer-comprise a unique family of receptor tyrosine kinases, in that as a group they play no essential role in embryonic development. TAM receptor signaling plays an especially important role in the engulfment and phagocytic clearance of apoptotic cells (ACs) and membranes in adult tissues.
TAM Receptor 相关产品(32)
- GC15779Cabozantinib (XL184, BMS-907351)CAS: 849217-68-1纯度: >99.50%
Cabozantinib (XL184,BMS-907351) 是一种新型 MET 和 VEGFR2 抑制剂,可同时抑制转移、血管生成和肿瘤生长。
- GC19166Glesatinib hydrochlorideCAS: 1123838-51-6纯度: >98.00%
Glesatinib hydrochloride (MGCD265 hydrochloride) 是一种具有口服活性的强效 MET/SMO 双重抑制剂。 Glesatinib hydrochloride 是一种酪氨酸激酶抑制剂,可拮抗 P-糖蛋白 (P-gp) 介导的非小细胞肺癌 (NSCLC) 中的多药耐药 (MDR)。
- GC19482GilteritinibCAS: 1254053-43-4纯度: >99.00%
Gilteritinib(ASP2215,Xospata)用于复发和/或难治性 AML (R/R AML)。
- GC62597DS-1205b free baseCAS: 1855860-24-0纯度: >99.50%
DS-1205b free base 是一种有效和选择性的 AXL 激酶抑制剂,IC50 值为 1.3 nM。DS-1205b free base 还可以抑制 MER,MET 和 TRKA,IC50 值分别为 63、104 和 407 nM。 DS-1205b free base 可以抑制细胞迁移和肿瘤生长。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10408 | 2-D08 | 144707-18-6 | >98.00% | |
2-D08是一种合成黄酮和具有细胞通透性的小泛素样修饰蛋白(SUMO)抑制剂,也能抑制Axl靶点,IC 50 为0.49nM。 | ||||
| GC13500 | UNC2881 | 1493764-08-1 | >99.50% | |
A Mer kinase inhibitor | ||||
| GC14214 | BMS-777607 | 1025720-94-8 | >99.00% | |
BMS-777607 是一种泛 TAM 抑制剂,对不同类型的癌症显示出抗肿瘤活性。 | ||||
| GC14218 | TP-0903 | 1341200-45-0 | >99.50% | |
An Axl kinase inhibitor | ||||
| GC14241 | LDC1267 | 1361030-48-9 | >98.00% | |
A TAM family kinase inhibitor | ||||
| GC14488 | NPS-1034 | 1221713-92-3 | >98.00% | |
A dual MET/AXL inhibitor | ||||
| GC15779 | Cabozantinib (XL184, BMS-907351) | 849217-68-1 | >99.50% | |
Cabozantinib (XL184,BMS-907351) 是一种新型 MET 和 VEGFR2 抑制剂,可同时抑制转移、血管生成和肿瘤生长。 | ||||
| GC17618 | R428 | 1037624-75-1 | >99.50% / >99.00% | |
R428作为一种Axl抑制剂,在纳摩尔浓度下阻断Axl在其C端对接位点Tyr821上的自动磷酸化。 | ||||
| GC17793 | UNC2250 | 1493694-70-4 | >98.00% | |
A selective Mer kinase inhibitor | ||||
| GC18211 | Ningetinib | 1394820-69-9 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC19102 | CEP-40783 | 1437321-24-8 | >99.00% | |
A multi-kinase inhibitor | ||||
| GC19166 | Glesatinib hydrochloride | 1123838-51-6 | >98.00% | |
Glesatinib hydrochloride (MGCD265 hydrochloride) 是一种具有口服活性的强效 MET/SMO 双重抑制剂。 Glesatinib hydrochloride 是一种酪氨酸激酶抑制剂,可拮抗 P-糖蛋白 (P-gp) 介导的非小细胞肺癌 (NSCLC) 中的多药耐药 (MDR)。 | ||||
| GC19330 | SGI-7079 | 1239875-86-5 | >99.50% / >98.00% | |
An Axl kinase inhibitor | ||||
| GC19482 | Gilteritinib | 1254053-43-4 | >99.00% | |
Gilteritinib(ASP2215,Xospata)用于复发和/或难治性 AML (R/R AML)。 | ||||
| GC33271 | R916562 | 1037798-41-6 | - | |
R916562是有效的和有选择性的Axl/VEGF-R2双重抑制剂,IC50值分别为136和24nM。 | ||||
| GC36135 | Gilteritinib hemifumarate | 1254053-84-3 | >99.50% | |
A FLT3 inhibitor | ||||
| GC36744 | Ningetinib Tosylate | 1394820-77-9 | >99.50% | |
A multi-kinase inhibitor | ||||
| GC37733 | TAM-IN-2 | 2135642-56-5 | >99.50% | |
TAM-IN-2 是专利 US 20170275290 A1 中提到的 TAM 抑制剂,吡咯并三嗪化合物 0904。 | ||||
| GC37858 | UNC2541 | 1612782-86-1 | >99.00% | |
UNC2541 is a potent and specific inhibitor of Mer tyrosine kinase (MerTK) that binds in the MerTK ATP pocket with IC50 of 4.4 nM. UNC2541 inhibits phosphorylated MerTK (pMerTK) with EC50 of 510 nM. | ||||
| GC38580 | RU-301 | 1110873-99-8 | >99.50% | |
RU-301 is a pan-TAM receptor (Axl, Tyro3 and Mertk) inhibitor that blocks the Axl receptor dimerization site with Kd of 12 μM and IC50 of 10 μM, respectively. | ||||
| GC62266 | XL092 | 2367004-54-2 | >99.50% | |
XL092 (JUN04542) is an ATP-competitive inhibitor of multiple RTKs including MET, VEGFR2, AXL and MER, with IC50 values of 15 nM, 1.6 nM, 3.4 nM, and 7.2 nM in cell-based assays, respectively. | ||||
| GC62516 | UNC5293 | 2226789-82-6 | >99.00% | |
UNC5293 是一种 MERTK 选择性的有效抑制剂 (Ki=190 pM)。UNC5293 抑制 MERTK (IC50=0.9 nM),对 Axl、Tyro3 和 Flt3 更具选择性。UNC5293 表现出优异的小鼠药代动力学特性,并可以被用于骨髓白血病研究。 | ||||
| GC62597 | DS-1205b free base | 1855860-24-0 | >99.50% | |
DS-1205b free base 是一种有效和选择性的 AXL 激酶抑制剂,IC50 值为 1.3 nM。DS-1205b free base 还可以抑制 MER,MET 和 TRKA,IC50 值分别为 63、104 和 407 nM。 DS-1205b free base 可以抑制细胞迁移和肿瘤生长。 | ||||
| GC64071 | AZ14145845 | - | - | |
AZ14145845 是一种具有体内药效的高选择性I1/2型Mer/Axl双特异性激酶抑制剂。 | ||||
